Cassandra Jenkins

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated steatohepatitis, according to study data.

Fecal microbiota transplant, regardless of dose or route, was safe and associated with reduced hepatic encephalopathy recurrence among patients with cirrhosis receiving lactulose and rifaximin, according to a study in Journal of Hepatology.

Healio spoke with an expert about their study of U.S. and Canadian patients who had anaphylaxis to insect stings between 2010 and 2023, which revealed that those taking lipid-lowering medications experienced more severe reactions.

ORLANDO — In this Healio Video Perspective from Vision Expo East, Yair Yahav, CEO and founder of RevitalVision, discusses the U.S. launch of the company’s neurological therapy indicated to improve vision outcomes across various conditions.

Injectable naltrexone had a more favorable gastrointestinal and liver safety profile compared with other medications for alcohol use disorder, according to a research letter published in Clinical Gastroenterology and Hepatology.

ORLANDO — In this Healio Video Perspective from Vision Expo East, Trudi Charest discusses the importance of building a personal online brand as an eye care professional.

A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for hypertensive disorders of pregnancy, gestational diabetes, preterm birth and cesarean delivery.

Researchers found that women with hypertension who followed a very low-calorie ketogenic diet had lower systolic and diastolic blood pressure at 6 months than those who participated in intermittent fasting or had no dietary restrictions.

As of Feb. 1, there have been at least 24 million illnesses, 310,000 hospitalizations and 13,000 deaths across the United States related to influenza during the 2024-2025 season, according to the CDC.

NovaBay Pharmaceuticals has completed the sale of its Avenova brand and related assets to Physician Recommended Nutriceuticals for $11.5 million, according to a company press release.